DE2853500A1 - Verfahren zur bestimmung von vitamin b tief 12 in einer fluessigkeit - Google Patents
Verfahren zur bestimmung von vitamin b tief 12 in einer fluessigkeitInfo
- Publication number
- DE2853500A1 DE2853500A1 DE19782853500 DE2853500A DE2853500A1 DE 2853500 A1 DE2853500 A1 DE 2853500A1 DE 19782853500 DE19782853500 DE 19782853500 DE 2853500 A DE2853500 A DE 2853500A DE 2853500 A1 DE2853500 A1 DE 2853500A1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- mixture
- serum
- binding proteins
- labeled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 48
- 239000007788 liquid Substances 0.000 title claims description 17
- 239000011782 vitamin Substances 0.000 title claims description 12
- 229940088594 vitamin Drugs 0.000 title claims description 12
- 229930003231 vitamin Natural products 0.000 title claims description 11
- 235000013343 vitamin Nutrition 0.000 title claims description 11
- 150000003722 vitamin derivatives Chemical class 0.000 title claims description 11
- 210000002966 serum Anatomy 0.000 claims description 73
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims description 59
- 239000000203 mixture Substances 0.000 claims description 27
- 102000014914 Carrier Proteins Human genes 0.000 claims description 26
- 108091008324 binding proteins Proteins 0.000 claims description 26
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 23
- 239000011720 vitamin B Substances 0.000 claims description 22
- 229930003270 Vitamin B Natural products 0.000 claims description 21
- 235000019156 vitamin B Nutrition 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 17
- 239000000872 buffer Substances 0.000 claims description 13
- 230000027455 binding Effects 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 8
- 239000011236 particulate material Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 230000009137 competitive binding Effects 0.000 claims description 4
- 239000011343 solid material Substances 0.000 claims description 4
- 108010088751 Albumins Proteins 0.000 claims description 3
- 102000009027 Albumins Human genes 0.000 claims description 3
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 3
- HFWIMJHBCIGYFH-UHFFFAOYSA-N cyanoform Chemical compound N#CC(C#N)C#N HFWIMJHBCIGYFH-UHFFFAOYSA-N 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 2
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 229940045999 vitamin b 12 Drugs 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 241000195619 Euglena gracilis Species 0.000 description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000013048 microbiological method Methods 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- -1 sodium cyanide Chemical compound 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102400001066 Growth hormone-binding protein Human genes 0.000 description 1
- 101800000194 Growth hormone-binding protein Proteins 0.000 description 1
- 102000011409 Transcobalamins Human genes 0.000 description 1
- 108010023603 Transcobalamins Proteins 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229940029329 intrinsic factor Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5206977 | 1977-12-14 | ||
| GB7830301 | 1978-07-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2853500A1 true DE2853500A1 (de) | 1979-06-21 |
| DE2853500C2 DE2853500C2 (https=) | 1988-04-14 |
Family
ID=26266985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782853500 Granted DE2853500A1 (de) | 1977-12-14 | 1978-12-12 | Verfahren zur bestimmung von vitamin b tief 12 in einer fluessigkeit |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS54116293A (https=) |
| AU (1) | AU519485B2 (https=) |
| CA (1) | CA1104911A (https=) |
| CH (1) | CH638053A5 (https=) |
| DE (1) | DE2853500A1 (https=) |
| FR (1) | FR2412074A1 (https=) |
| NL (1) | NL7812106A (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989012826A1 (en) * | 1988-06-15 | 1989-12-28 | Beckman Instruments, Inc. | Vitamin b12 assay |
-
1978
- 1978-12-11 AU AU42396/78A patent/AU519485B2/en not_active Expired
- 1978-12-12 DE DE19782853500 patent/DE2853500A1/de active Granted
- 1978-12-12 FR FR7834937A patent/FR2412074A1/fr active Granted
- 1978-12-13 NL NL7812106A patent/NL7812106A/xx not_active Application Discontinuation
- 1978-12-13 CA CA317,888A patent/CA1104911A/en not_active Expired
- 1978-12-14 CH CH1274878A patent/CH638053A5/de not_active IP Right Cessation
- 1978-12-14 JP JP15376978A patent/JPS54116293A/ja active Granted
Non-Patent Citations (2)
| Title |
|---|
| Brit. J. of Haematology, Vol. 25, 1973, S. 359 * |
| Scand. J. clin. Lab. Invest., Vol. 27, 1971, S. 151-159 * |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7812106A (nl) | 1979-06-18 |
| CH638053A5 (en) | 1983-08-31 |
| FR2412074A1 (fr) | 1979-07-13 |
| JPS6342231B2 (https=) | 1988-08-22 |
| AU4239678A (en) | 1979-06-21 |
| FR2412074B1 (https=) | 1984-05-25 |
| JPS54116293A (en) | 1979-09-10 |
| AU519485B2 (en) | 1981-12-03 |
| CA1104911A (en) | 1981-07-14 |
| DE2853500C2 (https=) | 1988-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2936307C2 (https=) | ||
| DE2560554C2 (de) | Verfahren zum Nachweisen und Bestimmen von Ak:Ag-Komplexen in einer biologischen Fluidprobe | |
| EP0257352B1 (de) | Verfahren und Testkit zur Bestimmung freier Wirkstoffe in biologischen Flüssigkeiten | |
| DE3331627A1 (de) | Verfahren zur immunologischen bestimmung fuer proteine in koerperfluessigkeiten, unter verwendung monovalenter antikoerperfragmente | |
| DE2943423C2 (https=) | ||
| DE3312380A1 (de) | Verfahren zur abtrennung von haemoglobin a(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)c(pfeil abwaerts) | |
| EP0077515B1 (de) | Verfahren und Reagenz zur Bestimmung von glykosiliertem Hämoglobin | |
| EP0780687A2 (de) | Verfahren zur Herstellung eines synthetischen Kalibrators für Sandwich-Immunoassays | |
| DE3887596T2 (de) | Antikörper zum Propeptid des Prokollagen-III und seine Benutzung in einem Analyseverfahren. | |
| DE2806860C3 (de) | Verfahren zur Bestimmung der Konzentration der freien Fraktion eines Hormons in einer biologischen Flüssigkeit | |
| DE3137668A1 (de) | Verfahren zum testen auf vitamin b(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)2(pfeil abwaerts) und testsatz zu seiner durchfuehrung | |
| DE2707913C2 (de) | Verfahren zum Nachweis von rheumatoiden Faktoren | |
| EP0215457A2 (de) | Verfahren zur Bestimmung eines Partners einer Immunreaktion | |
| DE2725594C2 (de) | Verfahren zur Bestimmung der Konzentration freier Schilddrüsenhormone in Flüssigkeiten, insbesondere Blutseren | |
| EP0311094A2 (de) | Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B | |
| DE2853500C2 (https=) | ||
| EP0190765B1 (de) | Verfahren zur Bestimmung der Bindungskapazität des Thyroxin bindenden Globulins | |
| EP0337467B1 (de) | Verfahren zur Bestimmung von Thyroxin und dazu geeignete Standardlösung | |
| EP0583717B1 (de) | Verfahren und Standardlösung zur Bestimmung von Thyroxin (T4) oder Trijodthyronin (T3) | |
| DE3125538A1 (de) | "immunometrische sandwich-assaymethode mit zweiseitiger cross-reaktion" | |
| EP0034301A2 (de) | Verfahren zur Bestimmung von Immunkomplexen | |
| DE2225827C3 (de) | Verfahren zur Diagnostizierung von Hyperthyreose | |
| DE3147538C2 (de) | Verfahren zur Bestimmung von Transferrin und dazu geeignetes Mittel | |
| DE3045872C2 (de) | Immunologisch-diagnostisches Verfahren zum Nachweis und zur Bestimmung von Antikörpern | |
| DE19532655A1 (de) | Verfahren zur zweidimensionalen Bestimmung von Proben in Immunoassays |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: TECHNICON INSTRUMENTS CORP. (N.D.GES.D.STAATES DEL |
|
| 8328 | Change in the person/name/address of the agent |
Free format text: REICHEL, W., DIPL.-ING. LIPPERT, H., DIPL.-ING., PAT.-ANWAELTE, 6000 FRANKFURT |
|
| 8339 | Ceased/non-payment of the annual fee |